NewsRx

Search our medical news database

Neuroscience

Mediation of anticonvulsant and sedative effects of loreclezole clarified

Published in Gene Therapy Weekly, September 14th, 2006

A study from the United Kingdom has documented the role of gamma-aminobutyric acid type A (GABA(A)) beta 2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole.

"The majority of inhibitory neurotransmission in the brain is mediated by the GABA(A) receptor. The anticonvulsant loreclezole largely acts by potentiating GABA(A) receptors containing beta 2 and beta 3 subunits.

"We used a genetically modified mouse containing a loreclezole-insensitive beta 2 subunit (beta 2N265S) to determine the role of this subunit in mediating the sedative and anticonvulsive effects of loreclezole," wrote J.O. Groves and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook